PDT Partners’s AvePoint AVPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535K Sell
47,727
-24,600
-34% -$253K 0.03% 388
2026
Q1
$688K Sell
72,327
-112,208
-61% -$1.26M 0.04% 379
2025
Q4
$2.56M Sell
184,535
-22,100
-11% -$305K 0.17% 210
2025
Q3
$3.1M Sell
206,635
-81,555
-28% -$1.37M 0.2% 180
2025
Q2
$5.56M Buy
288,190
+10,386
+4% +$180K 0.31% 85
2025
Q1
$4.01M Buy
277,804
+115,912
+72% +$1.95M 0.28% 101
2024
Q4
$2.67M Buy
161,892
+34,645
+27% +$526K 0.24% 145
2024
Q3
$1.5M Hold
127,247
0.13% 284
2024
Q2
$1.33M Buy
127,247
+64,724
+104% +$561K 0.13% 287
2024
Q1
$495K Buy
+62,523
New +$492K 0.05% 454

Other funds holding AVPT

PDT Partners's AVPT Position: Q2 2026 in Review

PDT Partners reduced its AvePoint (AVPT) stake by 34% in Q2 2026, selling an estimated $253K and leaving 47,727 shares worth $535K. The position accounts for 0.03% of the portfolio, ranked #388.

PDT Partners first reported a position in AVPT in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.56M in Q2 2025. 253 funds tracked by Wall St. Rank hold AVPT as of Q2 2026.

  • PDT Partners held 47,727 shares of AvePoint worth $535K as of Q2 2026.
  • PDT Partners sold 24,600 AvePoint shares in Q2 2026, an estimated $253K.
  • AvePoint made up 0.03% of PDT Partners's portfolio in Q2 2026, its #388 holding.
  • PDT Partners first reported a position in AvePoint in Q1 2024 and has held it in 10 quarters since.
  • PDT Partners's AvePoint position peaked at $5.56M in Q2 2025.
  • 253 funds tracked by Wall St. Rank held AvePoint as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.